Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour

Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Mol Sci
Auteurs principaux: Shaik Fakiruddin, Kamal, Ghazalli, Nadiah, Lim, Moon Nian, Zakaria, Zubaidah, Abdullah, Syahril
Format: Artigo
Langue:Inglês
Publié: MDPI 2018
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6121609/
https://ncbi.nlm.nih.gov/pubmed/30060445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19082188
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires